These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22890076)

  • 1. Effect of ezetimibe on lipid and glucose metabolism after a fat and glucose load.
    Hiramitsu S; Miyagishima K; Ishii J; Matsui S; Naruse H; Shiino K; Kitagawa F; Ozaki Y
    J Cardiol; 2012 Nov; 60(5):395-400. PubMed ID: 22890076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind randomized clinical trial of the effects of ezetimibe on postprandial hyperlipidaemia and hyperglycaemia.
    Kikuchi K; Nezu U; Inazumi K; Miyazaki T; Ono K; Orime K; Shirakawa J; Sato K; Koike H; Wakasugi T; Sato M; Kawakami C; Watanabe S; Yamakawa T; Terauchi Y
    J Atheroscler Thromb; 2012; 19(12):1093-101. PubMed ID: 22878697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised four-intervention crossover study investigating the effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and triacylglycerols in middle-aged men.
    Brynes AE; Mark Edwards C; Ghatei MA; Dornhorst A; Morgan LM; Bloom SR; Frost GS
    Br J Nutr; 2003 Feb; 89(2):207-18. PubMed ID: 12575905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia.
    Masuda D; Nakagawa-Toyama Y; Nakatani K; Inagaki M; Tsubakio-Yamamoto K; Sandoval JC; Ohama T; Nishida M; Ishigami M; Yamashita S
    Eur J Clin Invest; 2009 Aug; 39(8):689-98. PubMed ID: 19490064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of atorvastatin monotherapy and low-dose atorvastatin/ezetimibe combination on fasting and postprandial triglycerides in combined hyperlipedemia.
    Lee SH; Park S; Kang SM; Jang Y; Chung N; Choi D
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):65-71. PubMed ID: 21386036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe.
    Kater AL; Batista MC; Ferreira SR
    Metabolism; 2010 Jun; 59(6):921-6. PubMed ID: 20199786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A low-protein diet exacerbates postprandial chylomicron concentration in moderately dyslipidaemic subjects in comparison to a lean red meat protein-enriched diet.
    Mamo JC; James AP; Soares MJ; Griffiths DG; Purcell K; Schwenke JL
    Eur J Clin Nutr; 2005 Oct; 59(10):1142-8. PubMed ID: 16015257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
    Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
    Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.
    Olijhoek JK; Hajer GR; van der Graaf Y; Dallinga-Thie GM; Visseren FL
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):145-50. PubMed ID: 18670365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial lipemia after short-term variation in dietary fat and carbohydrate.
    Koutsari C; Malkova D; Hardman AE
    Metabolism; 2000 Sep; 49(9):1150-5. PubMed ID: 11016896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of short-term low- and high-carbohydrate diets on postprandial metabolism in non-diabetic and diabetic subjects.
    Culling KS; Neil HA; Gilbert M; Frayn KN
    Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):345-51. PubMed ID: 18083355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
    Zheng S; Hoos L; Cook J; Tetzloff G; Davis H; van Heek M; Hwa JJ
    Eur J Pharmacol; 2008 Apr; 584(1):118-24. PubMed ID: 18329014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of ezetimibe-induced attenuation of postprandial hypertriglyceridemia.
    Sandoval JC; Nakagawa-Toyama Y; Masuda D; Tochino Y; Nakaoka H; Kawase R; Yuasa-Kawase M; Nakatani K; Inagaki M; Tsubakio-Yamamoto K; Ohama T; Matsuyama A; Nishida M; Ishigami M; Komuro I; Yamashita S
    J Atheroscler Thromb; 2010 Sep; 17(9):914-24. PubMed ID: 20543519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
    Taggart C; Gibney J; Owens D; Collins P; Johnson A; Tomkin GH
    Diabet Med; 1997 Dec; 14(12):1051-8. PubMed ID: 9455933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of metformin and rosiglitazone on postprandial lipid metabolism in obese insulin-resistant subjects.
    James AP; Watts GF; Mamo JC
    Diabetes Obes Metab; 2005 Jul; 7(4):381-9. PubMed ID: 15955124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of ezetimibe added to atorvastatin versus up titration of atorvastatin to 40 mg in Patients > or = 65 years of age (from the ZETia in the ELDerly [ZETELD] study).
    Zieve F; Wenger NK; Ben-Yehuda O; Constance C; Bird S; Lee R; Hanson ME; Jones-Burton C; Tershakovec AM
    Am J Cardiol; 2010 Mar; 105(5):656-63. PubMed ID: 20185012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dietary protein on lipid metabolism in high fructose fed humans.
    Bortolotti M; Dubuis J; Schneiter P; Tappy L
    Clin Nutr; 2012 Apr; 31(2):238-45. PubMed ID: 22019201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial.
    Hajer GR; Dallinga-Thie GM; van Vark-van der Zee LC; Olijhoek JK; Visseren FL
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):870-7. PubMed ID: 18394022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of breakfast meal composition on second meal metabolic responses in adults with Type 2 diabetes mellitus.
    Clark CA; Gardiner J; McBurney MI; Anderson S; Weatherspoon LJ; Henry DN; Hord NG
    Eur J Clin Nutr; 2006 Sep; 60(9):1122-9. PubMed ID: 16670695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.